# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5098382 | B | Inhibition of BTK (unknown origin) incubated 30 mins by FRET assay | Homo sapiens | 50 | ALA5096196 | single protein format | Scientific Literature | |
2. | ALA5098387 | T | Antiproliferative activity against human PBMC preincubated for 30 mins followed by IL-4 stimulation for 3 days by cell titer glo assay | Homo sapiens | 27 | ALA5096196 | cell-based format | Scientific Literature | |
3. | ALA5098402 | B | Inhibition of CD69 (unknown origin) in PBMC preincubated for 30 mins followed by IL-4 stimulation for 3 days by cell titer glo assay | Homo sapiens | 3 | ALA5096196 | cell-based format | Scientific Literature | |
4. | ALA5098403 | P | Lipophilicity, logD of compound | 2 | ALA5096196 | small-molecule physicochemical format | Scientific Literature | ||
5. | ALA5098404 | P | Kinetic solubility of compound at pH 6.8 | 2 | ALA5096196 | small-molecule physicochemical format | Scientific Literature | ||
6. | ALA5098405 | A | Plasma protein binding in human assessed as unbound fraction at 2 uM by rapid equilibrium dialysis analysis | Homo sapiens | 3 | ALA5096196 | cell-free format | Scientific Literature | |
7. | ALA5098406 | A | Plasma protein binding in rat assessed as unbound fraction at 2 uM by rapid equilibrium dialysis analysis | Rattus norvegicus | 3 | ALA5096196 | cell-free format | Scientific Literature | |
8. | ALA5098407 | A | Plasma clearance in iv dosed Sprague-Dawley rat assessed as hepatic blood flow | Rattus norvegicus | 2 | ALA5096196 | organism-based format | Scientific Literature |